Moors & Cabot’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Moors & Cabot’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,651	Closed	-$159K	–	857
2022 Q3	$159K	Sell	10,651 -60	-0.6%	-$992	0.01%	725
2022 Q2	$176K	Buy	+10,711	New	+$184K	0.01%	713
2022 Q1	–	Sell	-9,909	Closed	-$251K	–	913
2021 Q4	$251K	Buy	9,909 +1,012	+11%	+$26.1K	0.02%	694
2021 Q3	$240K	Buy	8,897 +563	+7%	+$16.1K	0.02%	681
2021 Q2	$241K	Sell	8,334 -619	-7%	-$17.1K	0.02%	662
2021 Q1	$237K	Buy	+8,953	New	+$254K	0.02%	624

Other funds holding BMEZ

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Moors & Cabot's BMEZ Position: Q4 2022 in Review

Moors & Cabot sold out of BlackRock Health Sciences Trust II (BMEZ) in Q4 2022, closing a stake of 10,651 shares — an estimated $159K sold.

Moors & Cabot first reported a position in BMEZ in Q1 2021 and held it in 6 quarters. The position peaked at $251K in Q4 2021. 82 funds tracked by Wall St. Rank hold BMEZ as of Q4 2022.

Moors & Cabot reported no remaining BlackRock Health Sciences Trust II position as of Q4 2022 after selling out during the quarter.
Moors & Cabot sold 10,651 BlackRock Health Sciences Trust II shares in Q4 2022, an estimated $159K.
Moors & Cabot first reported a position in BlackRock Health Sciences Trust II in Q1 2021 and held it in 6 quarters.
Moors & Cabot's BlackRock Health Sciences Trust II position peaked at $251K in Q4 2021.
82 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q4 2022.

Based on Moors & Cabot's 13F filing for Q4 2022, filed 7 Feb 2023.